Back to BlackRock, Inc. BlackRock, Inc.

PLXPLX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in PROTALIX BIOTHERAPEUTICS INC

BlackRock, Inc. holds 4M shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $9.4M as of 2026-Q2. The position was increased (+11.9% shares). PLX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$9.4M

Current Shares

4M

Total Value Change

+$9M

Total Shares Change

+3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4M
+11.9%
$9.4M0.0%$2.33
31
2026-Q1
Decreased
3.6M
-0.8%
$7.8M0.0%$2.83
0
2025-Q4
Increased
3.6M
+2.7%
$6.6M0.0%$1.74
28
2025-Q3
Increased
3.6M
+5.4%
$7.9M0.0%$2.16
29
2025-Q2
Increased
3.4M
+1223.8%
$5M0.0%$1.54
43
2025-Q1
Increased
254,535
+13.3%
$651,6100.0%$2.58
19
2024-Q4
New
224,657
-
$422,3540.0%$1.89
37

Other major holders of PLX: BlackRock Finance, Inc., Steward Partners Investment Advisory, LLC, BLACKROCK ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used